Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation
- 1 November 1996
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 11 (6) , 310-317
- https://doi.org/10.1007/bf01747190
Abstract
During cardiopulmonary bypass (CPB) mechanical stress and the contact of blood with artificial surfaces lead to the activation of pro- and anticoagulant systems and the complement cascade, and to changes in cellular components. This phenomenon causes the “postperfusion-syndrome”, with leukocytosis, increased capillary permeability, accumulation of interstitial fluid, and organ dysfunction. In this study, we focused on the influence of the extracorporeal circulation, sternotomy, and heparin administration on the activation of coagulation and fibrinolysis. In 15 patients we investigated coagulation parameters before, during and post CPB, i.e., fibrinogen, antithrombin (AT) III, thrombin-antithrombin complex (TAT), prothrombin fragments F1 + 2 (F1 + 2), factor (F) XIIa, tissue factor (TF), and parameters of the fibrinolytic system, i.e., plasmin-antiplasmin-complex (PAP), D-dimer, tissueplasminogen-activator (tPA), urokinase-type plasminogen activator (uPA), and plasminogen-activator inhibitor type 1 (PAI 1). The results demonstrate distinct alterations in the above mentioned parameters. Despite administration of a high dose of heparin (activated clotting time [ACT] > 450s) combined with a low dose of aprotinin, activation of the coagulation and fibrinolytic pathways was observed. We found this activation was mainly caused by CPB and not by sternotomy. The activation of coagulation was due to foreign surface contact (F XII ⇒ F XIIa) as well as to an effect of tissue factor release in the late phase of CPB. The enhanced fibrinolytic activity during CPB was, at least in part, caused by tPA and was followed by PAI 1 release.Keywords
This publication has 40 references indexed in Scilit:
- Resting Hemodynamics After Total Versus Standard Orthotopic Heart TransplantationThe Thoracic and Cardiovascular Surgeon, 1996
- Cerebral blood flow during cardiopulmonary bypass: Influence of temperature and pH management strategyThe Annals of Thoracic Surgery, 1995
- Factor XII activation by artificial surfaces and its reduction by phosphorylcholine coatingsBlood Coagulation & Fibrinolysis, 1995
- Centrifugal and roller pumps — are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?Heart and Vessels, 1995
- Cardiopulmonary Bypass Using Centrifugal PumpVascular Surgery, 1992
- Intra- and Postoperative Fibrinolysis in Patients Undergoing Cardiopulmonary Bypass SurgeryPathophysiology of Haemostasis and Thrombosis, 1991
- Activation of pro‐urokinase by the human T cell‐associated serine proteinase HuTSP‐1FEBS Letters, 1990
- Complement Activation in Cardiopulmonary Bypass, with Special Reference to Anaphylatoxin Production in Membrane and Bubble OxygenatorsThe Annals of Thoracic Surgery, 1988
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Hemostatic Defects Induced by Cardiopulmonary BypassVascular Surgery, 1975